CONMED (CNMD) news

ConMed sees FY adj EPS $4.48 to $4.60, saw $4.30 to $4.45

CONMED Corporation (NYSE: CNMD) has raised its full-year 2025 EPS guidance to a range of $4.48 to $4.60, up from its previous forecast of $4.25 to $4.40. The updated outlook reflects continued operational improvements and progress in addressing supply chain challenges that impacted parts of the…

Needham says Conmed worth $46-$53 per share in a takeover

Needham & Company has revised its price target for CONMED Corporation (NYSE: CNMD), suggesting the medical device company could be valued between $46 and $53 per share in the event of a potential takeover. This assessment follows reports that CONMED is exploring strategic options after receiving…

Conmed is said to weigh sale after takeover interest - Bloomberg News

Conmed Corporation (NYSE: CNMD) is reportedly considering a potential sale following emerging takeover interest, according to recent market reports . The company’s stock has shown notable volatility in response to the speculation, with shares rising on news of the reported interest. While no formal…

Conmed is said to weigh sale after takeover interest

Conmed Corp: BMO initiates coverage with market perform rating; target price $36

BMO Capital Markets has initiated coverage of Conmed Corp (NYSE:CNMD), assigning the stock a "market perform" rating and establishing a target price of $36 . The decision follows a comprehensive review of the company’s financial performance, market positioning, and growth prospects. Analysts…